Meta Information
ID:bilberry-extract
Name:Bilberry Extract
Schema Version:2.4_uniform_evidence_2026_06_18
Created
2026-07-02T07:04:55Z
Model
phase-b-newfiles-claude-opus-4.8
Interactions
Target id:
/class/anticoagulants-antiplatelets
Target name:
Anticoagulants / antiplatelets
Severity:
minor
Interaction type:
adverse
Nature:
relative
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Bilberry anthocyanins have mild antiplatelet activity that could add to blood thinners.
Actionable advice:
Usually minor; watch for bruising if combined with anticoagulants/antiplatelets.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Anthocyanins have mild antiplatelet effects; low-magnitude additive bleeding risk.
Label source:
Class inference
Action type:
monitor
Target id:
/class/antidiabetic-medications
Target name:
Antidiabetic medications
Severity:
minor
Interaction type:
adverse
Nature:
relative
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Bilberry may modestly lower blood glucose.
Actionable advice:
It is a good idea to check glucose if combining with diabetes medication.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Bilberry has mild glucose-lowering activity; low-certainty.
Label source:
Class inference
Action type:
monitor